Determinants of long-acting reversible contraception use compared between respondents
| Variables | Public N=208 N (%) | Private N=210 N (%) | Total N=418 N (%) | χ2 | P value |
| Age (years) | |||||
| <20 | 63 (30.3) | 121 (57.6) | 184 (44.1) | 11.414 | 0.003 |
| 20–24 | 124 (59.6) | 84 (40.0) | 208 (49.7) | ||
| 25–29 | 21 (10.1) | 5 (2.4) | 26 (6.2) | ||
| Mean age±SD | 21.1±2.5 | 19.3±2.1 | 7.861 | <0.001 | |
| Age Range | 16–28 | 15–28 | |||
| Religion | |||||
| Islam | 35 (16.8) | 54 (25.7) | 89 (21.3) | 4.775 | 0.072 |
| Christianity | 173 (83.2) | 156 (74.3) | 329 (78.7) | ||
| Marital status | |||||
| Married | 12 (5.8) | 7 (3.3) | 19 (4.5) | 4.775 | 0.004 |
| Single | 196 (94.2) | 203 (96.7) | 399 (95.5) | ||
| Ethnicity | |||||
| Yoruba | 170 (81.7) | 118 (56.2) | 288 (68.9) | 3.723 | 0.293 |
| Hausa | 14 (6.7) | 18 (8.6) | 32 (7.7) | ||
| Igbo | 21 (10.1) | 40 (19.0) | 61 (14.6) | ||
| Others | 3 (1.5) | 34 (16.2) | 37 (8.8) | ||
| Knowledge of LARC | |||||
| Good | 49 (23.6) | 70 (33.3) | 119 (28.5) | 4.904 | 0.027 |
| Poor | 159 (76.4) | 140 (66.7) | 299 (71.5) | ||
| Fear of pain | |||||
| Yes | 36 (17.3) | 27 (12.9) | 63 (15.1) | 1.617 | 0.204 |
| No | 172 (82.7) | 183 (87.1) | 355 (54.9) | ||
| Fear of side effects | |||||
| Yes | 28 (13.5) | 30 (14.3) | 58 (13.9) | 0.059 | 0.807 |
| No | 180 (86.5) | 180 (85.7) | 360 (86.1) | ||
| Partner’s preference | |||||
| Yes | 30 (14.4) | 20 (9.5) | 50 (12.0) | 2.382 | 0.123 |
| No | 178 (85.6) | 190 (90.5) | 368 (88.0) | ||
| Availability at the school health | |||||
| Yes | 32 (13.5) | 20 (4.8) | 52 (12.4) | 3.295 | 0.069 |
| No | 176 (86.5) | 190 (95.2) | 366 (87.6) | ||
| Use by colleagues | |||||
| Yes | 57 (27.4) | 58 (27.6) | 115 (27.5) | 0.002 | 0.961 |
| No | 151 (72.6) | 152 (72.4) | 303 (72.5) |
LARC, long-acting reversible contraception.